Liquid Embolic Agent Market (2025 - 2033)

Size, Share & Trends Analysis Report By Product Type (Ethylene Vinyl Alcohol Copolymer, Cyanoacrylates), By Application (Arteriovenous Malformations, Hypervascular Tumors), By End Use, By Region, And Segment Forecasts

Market Segmentation

Liquid Embolic Agent Product Type Outlook (Revenue, USD Million, 2021 - 2033)
- Ethylene Vinyl Alcohol Copolymer (EVOH)
- Cyanoacrylates
  - N-BCA (n-Butyl Cyanoacrylate)
  - N-HCA (n-Hexyl Cyanoacrylate)
- Others
Liquid Embolic Agent Application Outlook (Revenue, USD Million, 2021 - 2033)
- Arteriovenous Malformations (AVM)
- Hypervascular Tumors
- Peripheral Vasculature Hemorrhage
- Others
Liquid Embolic Agent End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
Liquid Embolic Agent Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
  - North America Liquid Embolic Agent Market, By Product Type
    - Ethylene Vinyl Alcohol Copolymer (EVOH)
    - Cyanoacrylates
      - N-BCA (n-Butyl Cyanoacrylate)
      - N-HCA (n-Hexyl Cyanoacrylate)
    - Others
  - North America Liquid Embolic Agent Market, By Application
    - Arteriovenous Malformations (AVM)
    - Hypervascular Tumors
    - Peripheral Vasculature Hemorrhage
    - Others
  - North America Liquid Embolic Agent Market, By End Use
    - Hospitals
    - Specialty Clinics
    - Ambulatory Surgical Centers (ASCs)
    - Others
  - U.S.
    - U.S. Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - U.S. Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - U.S. Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Canada
    - Canada Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Canada Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Canada Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Mexico
    - Mexico Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Mexico Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Mexico Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
- Europe
  - Europe Liquid Embolic Agent Market, By Product Type
    - Ethylene Vinyl Alcohol Copolymer (EVOH)
    - Cyanoacrylates
      - N-BCA (n-Butyl Cyanoacrylate)
      - N-HCA (n-Hexyl Cyanoacrylate)
    - Others
  - Europe Liquid Embolic Agent Market, By Application
    - Arteriovenous Malformations (AVM)
    - Hypervascular Tumors
    - Peripheral Vasculature Hemorrhage
    - Others
  - Europe Liquid Embolic Agent Market, By End Use
    - Hospitals
    - Specialty Clinics
    - Ambulatory Surgical Centers (ASCs)
    - Others
  - UK
    - UK Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - UK Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - UK Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Germany
    - Germany Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Germany Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Germany Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - France
    - France Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - France Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - France Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Italy
    - Italy Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Ohers
    - Italy Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Italy Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Spain
    - Spain Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Spain Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Spain Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Denmark
    - Denmark Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Denmark Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Denmark Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Sweden
    - Sweden Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Sweden Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Sweden Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Norway
    - Norway Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Norway Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Norway Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
- Asia Pacific
  - Asia Pacific Liquid Embolic Agent Market, By Product Type
    - Ethylene Vinyl Alcohol Copolymer (EVOH)
    - Cyanoacrylates
      - N-BCA (n-Butyl Cyanoacrylate)
      - N-HCA (n-Hexyl Cyanoacrylate)
    - Others
  - Asia Pacific Liquid Embolic Agent Market, By Application
    - Arteriovenous Malformations (AVM)
    - Hypervascular Tumors
    - Peripheral Vasculature Hemorrhage
    - Others
  - Asia Pacific Liquid Embolic Agent Market, By End Use
    - Hospitals
    - Specialty Clinics
    - Ambulatory Surgical Centers (ASCs)
    - Others
  - Japan
    - Japan Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Japan Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Japan Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - India
    - India Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - India Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - India Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - China
    - China Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - China Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - China Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Australia
    - Australia Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Australia Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Australia Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Thailand
    - Thailand Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Thailand Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Thailand Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - South Korea
    - South Korea Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - South Korea Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - South Korea Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
- Latin America
  - Latin America Liquid Embolic Agent Market, By Product Type
    - Ethylene Vinyl Alcohol Copolymer (EVOH)
    - Cyanoacrylates
      - N-BCA (n-Butyl Cyanoacrylate)
      - N-HCA (n-Hexyl Cyanoacrylate)
    - Others
  - Latin America Liquid Embolic Agent Market, By Application
    - Arteriovenous Malformations (AVM)
    - Hypervascular Tumors
    - Peripheral Vasculature Hemorrhage
    - Others
  - Latin America Liquid Embolic Agent Market, By End Use
    - Hospitals
    - Specialty Clinics
    - Ambulatory Surgical Centers (ASCs)
    - Others
  - Brazil
    - Brazil Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Brazil Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Brazil Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Argentina
    - Argentina Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Argentina Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Argentina Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
- Middle East and Africa
  - Middle East and Africa Liquid Embolic Agent Market, By Product Type
    - Ethylene Vinyl Alcohol Copolymer (EVOH)
    - Cyanoacrylates
      - N-BCA (n-Butyl Cyanoacrylate)
      - N-HCA (n-Hexyl Cyanoacrylate)
    - Others
  - Middle East and Africa Liquid Embolic Agent Market, By Application
    - Arteriovenous Malformations (AVM)
    - Hypervascular Tumors
    - Peripheral Vasculature Hemorrhage
    - Others
  - Middle East and Africa Liquid Embolic Agent Market, By End Use
    - Hospitals
    - Specialty Clinics
    - Ambulatory Surgical Centers (ASCs)
    - Others
  - South Africa
    - South Africa Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - South Africa Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - South Africa Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Saudi Arabia
    - Saudi Arabia Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Saudi Arabia Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Saudi Arabia Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - UAE
    - UAE Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - UAE Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - UAE Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others
  - Kuwait
    - Kuwait Liquid Embolic Agent Market, By Product Type
      - Ethylene Vinyl Alcohol Copolymer (EVOH)
      - Cyanoacrylates
        
        N-BCA (n-Butyl Cyanoacrylate)
        
        N-HCA (n-Hexyl Cyanoacrylate)
      - Others
    - Kuwait Liquid Embolic Agent Market, By Application
      - Arteriovenous Malformations (AVM)
      - Hypervascular Tumors
      - Peripheral Vasculature Hemorrhage
      - Others
    - Kuwait Liquid Embolic Agent Market, By End Use
      - Hospitals
      - Specialty Clinics
      - Ambulatory Surgical Centers (ASCs)
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments